Cellbricks
Berlin, DE · 2 known investors
Cellbricks Therapeutics is a preclinical biotech company developing implantable tissue grafts using proprietary bioprinting technology, biomaterials, and human cells for regenerative medicine applications. The company combines deep tech innovation to restore tissue function at clinical scale across multiple therapeutic programs.
Founders & leadership
AL
Alexander LeutnerCo-CEO (Business) & Co-founder
DT
Dr. Tobias LamCTO & Co-founder
AT
Alexander ThomasSoft Tissue Program Lead & Co-founder
Investors · 2
Frequently asked questions
- What does Cellbricks do?
- Cellbricks Therapeutics is a preclinical biotech company developing implantable tissue grafts using proprietary bioprinting technology, biomaterials, and human cells for regenerative medicine applications. The company combines deep tech innovation to restore tissue function at clinical scale across multiple therapeutic programs.
- Who founded Cellbricks?
- Cellbricks was founded by Alexander Leutner, Dr. Tobias Lam, Alexander Thomas.
- Who are Cellbricks's investors?
- Cellbricks's investors include ACT Venture Partners, Creative Destruction Lab (CDL).
- Where is Cellbricks headquartered?
- Cellbricks is headquartered in Berlin, DE.